Brief: Rhinomed Ltd Says Revenue For FY22 Q2 Was A$2.025 Mln, Up 17% On Previous Quarter
25/01/2022 01:45
Jan 25 (Reuters) - Rhinomed Ltd RNO.AX :
* REVENUE FOR FY22 Q2 WAS A$2.025M, UP 17% ON PREVIOUS
QUARTER
Source text for Eikon: ID:nASXcbQWCs
Further company coverage: RNO.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rhinomed
See all newsBrief: Rhinomed Says Q2 Revenues Of A$1.8M
Australia's Rhinomed hits record low after delisting and capital raise announcement
Brief: Rhinomed Formally Applies To ASX Requesting Removal From Official List
Brief: Rhinomed Ltd Seeks Trading Halt
Brief: Rhinomed Says It Is Implementing Measures To Reduce Cash Burn, Including Reduction In Headcount